MedPath

The effect of Fenoculum vulgrate on serum prolactin level

Phase 2
Conditions
Serum prolactin level.
Prolactin- adverse effect in theraputic use
Registration Number
IRCT2012121011710N1
Lead Sponsor
Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
46
Inclusion Criteria

Exclusive Breast feeding; perimyparity; BMI 19.8-26; age 18-35 years old; Term delivery; 4-6 months after birth; Mothers who say about shortage of their milk despite correct's way Breast feeding; Amenoreha after delivery. Exclusion criteria: Any type of mental disease, liver diseases & cancer; use of hormone contraceptive; Any kind of events during stud; Stopping Breast feeding; Consume of Antagonist's Dopamin's Drug.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum prolactin level blood. Timepoint: before intervention, 15 days after intervention. Method of measurement: Elisa kit, Elisa Rider system.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath